These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36950499)

  • 1. Palliative Care for Patients with End-Stage Liver Disease.
    Philips CA; Kedarisetty CK
    J Clin Exp Hepatol; 2023; 13(2):319-328. PubMed ID: 36950499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Management of Cirrhotic Cardiomyopathy.
    Kaur H; Premkumar M
    J Clin Exp Hepatol; 2022; 12(1):186-199. PubMed ID: 35068798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.
    Blaya D; Pose E; Coll M; Lozano JJ; Graupera I; Schierwagen R; Jansen C; Castro P; Fernandez S; Sidorova J; Vasa-Nicotera M; Solà E; Caballería J; Trebicka J; Ginès P; Sancho-Bru P
    JHEP Rep; 2021 Apr; 3(2):100233. PubMed ID: 33665588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for End-stage Liver Disease.
    Singal AK; Kamath PS
    J Clin Exp Hepatol; 2013 Mar; 3(1):50-60. PubMed ID: 25755471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.
    Chang J; Höfer P; Böhling N; Lingohr P; Manekeller S; Kalff JC; Dohmen J; Kaczmarek DJ; Jansen C; Meyer C; Strassburg CP; Trebicka J; Praktiknjo M
    JHEP Rep; 2022 Mar; 4(3):100442. PubMed ID: 35198929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
    Rajesh S; Philips CA; Betgeri SS; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2021 Aug; 40(4):361-372. PubMed ID: 34324168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.
    Li M; Li K; Tang S; Lv Y; Wang Q; Wang Z; Luo B; Niu J; Zhu Y; Guo W; Bai W; Wang E; Xia D; Wang Z; Li X; Yuan J; Yin Z; Trebicka J; Han G
    JHEP Rep; 2022 May; 4(5):100448. PubMed ID: 35313729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recompensation in Cirrhosis: Current Evidence and Future Directions.
    Sharma S; Roy A
    J Clin Exp Hepatol; 2023; 13(2):329-334. PubMed ID: 36950490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery in a patient with liver disease.
    Rai R; Nagral S; Nagral A
    J Clin Exp Hepatol; 2012 Sep; 2(3):238-46. PubMed ID: 25755440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Complications in Cirrhosis.
    Premkumar M; Anand AC
    J Clin Exp Hepatol; 2022; 12(4):1150-1174. PubMed ID: 35814522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.
    Praharaj DL; Anand AC
    J Clin Exp Hepatol; 2022; 12(2):575-594. PubMed ID: 35535075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.
    Gupta T; Dhiman RK; Rathi S; Agrawal S; Duseja A; Taneja S; Chawla Y
    J Clin Exp Hepatol; 2017 Mar; 7(1):9-15. PubMed ID: 28348465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
    Horhat A; Bureau C; Thabut D; Rudler M
    United European Gastroenterol J; 2021 Mar; 9(2):203-208. PubMed ID: 32819214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
    Praktiknjo M; Abu-Omar J; Chang J; Thomas D; Jansen C; Kupczyk P; Schepis F; Garcia-Pagan JC; Merli M; Meyer C; Strassburg CP; Pieper CC; Trebicka J
    JHEP Rep; 2021 Jun; 3(3):100264. PubMed ID: 34013182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids.
    Sharma S; Agarwal S; Gopi S; Anand A; Mohta S; Gunjan D; Yadav R; Saraya A
    J Clin Exp Hepatol; 2021; 11(2):171-180. PubMed ID: 33746441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.